Blood test monitoring after kidney transplant
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study tests whether a special blood test can help monitor your new kidney after transplant. It may help doctors spot problems earlier and improve kidney health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be about to receive a kidney transplant, or have received one within the past 29 days.
- You can have received a kidney before (first or repeat), from a living or deceased donor.
- You must be willing to have your blood tested with the study's special tests, called TruGraf and TRAC.
- You cannot have had a previous transplant of any other solid organ (like heart, liver, or lung), stem cells, or bone marrow.
- You cannot have hepatitis B, hepatitis C, or HIV, and you cannot be pregnant or planning pregnancy in the next 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.
This study looks at kidney transplant patients who are getting a kidney biopsy for usual clinical reasons. It tests whether special blood test results (from a sample taken as part of the study) can help spot transplant kidney problems earlier or more accurately.
This study looks at a new blood test to help monitor the health of your transplanted kidney and check for early signs of rejection. The test will be done as part of your usual care after a kidney transplant.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.
Hear when a new Biomarkers / Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.